target price 22 cents, page-24

re: sp prices relative to the market This stock needs to partner up with a major but is caught in a catch 22. No partner, no new trial. No successful trial, no partner. If their last trial was misunderstood by the market as a co. announcement suggested then why haven't they been able to produce independent followup analysis to counter the negative interpretations? Their recent diversification probably provides the answer.